In this free webinar, learn how one institution successfully
implemented a rapid multiplex blood culture identification panel
into their antimicrobial stewardship program. Attendees will learn
how rapid blood culture identification results can improve the
management of patients with bacteremia. The featured speaker will
discuss how to identify outcomes that can be used to demonstrate
the value of rapid blood culture identification.
TORONTO, May 14, 2024
/PRNewswire-PRWeb/ -- Bloodstream infections are a common cause of
morbidity and mortality despite advances in antimicrobial agents
and sepsis management. Over the past decade, several molecular
methods have been integrated into routine clinical microbiology
workflows due to their ability to rapidly and simultaneously detect
microorganisms and antimicrobial resistance genes from positive
blood cultures.
The impact on clinical outcomes is only
realized when rapid BCID results are partnered with active
stewardship interventions.
Incorporating a rapid multiplex molecular blood culture
identification (BCID) panel can be an important strategy to improve
the outcomes of patients with bacteremia and improve antimicrobial
utilization. However, the impact on clinical outcomes is only
realized when rapid BCID results are partnered with active
stewardship interventions.
In this webinar, the expert speaker will share insights gained
through the implementation of a rapid syndromic cobas® eplex BCID
panels in tandem with real-time antimicrobial stewardship
interventions, which resulted in improved antimicrobial use and
patient outcomes at a large academic medical center.
This webinar focuses on the integration of rapid blood culture
identification into an antimicrobial stewardship program, how
antimicrobial stewardship programs make rapid BCID results
actionable and how the results can be used to demonstrate the value
of the test and impact on antimicrobial stewardship.
Register for this webinar today to understand how active
diagnostic stewardship interventions can help optimize the outcomes
of patients with bacteremia.
Join Ryan Shields, PharmD, MS,
Associate Professor of Medicine, University of
Pittsburgh, Department of Medicine, for the live webinar on
Thursday, May 30, 2024, at
1pm EDT (10am
PDT).
For more information, or to register for this event, visit
Leveraging Active Diagnostic Stewardship Interventions to Optimize
the Outcomes of Patients with Bacteremia.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading
provider of educational webinars and digital content to the global
life science, food, healthcare and medical device communities.
Every year, thousands of industry practitioners (from
pharmaceutical, biotechnology, food, healthcare and medical device
companies, private & academic research institutions, healthcare
centers, etc.) turn to Xtalks for access to quality content. Xtalks
helps professionals stay current with industry developments,
regulations and jobs. Xtalks webinars also provide perspectives on
key issues from top industry thought leaders and service
providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit
https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416)
977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com
View original content to download
multimedia:https://www.prweb.com/releases/leveraging-active-diagnostic-stewardship-interventions-to-optimize-the-outcomes-of-patients-with-bacteremia-upcoming-webinar-hosted-by-xtalks-302144501.html
SOURCE Xtalks